In this unprecedented age of technology and communication, many wonder why the healthcare industry has traditionally not been on the cutting edge.
Browsing: Uncategorized
OncoSec intends to use proceeds from the offering for general corporate purposes, including clinical trial expenses and research and development expenses.
The company has been selected for the shortlist of the 5th Annual Vaccine Industry Excellence (ViE) Awards in the category of Best Therapeutic Vaccine.
Brachytherapy, a form of radiation therapy where radioactive seeds – or isotopes – are placed near or inside the tumor to emit radiation, is one of the most intriguing both in the medical and investor community.
Brachytherapy is considered to be one of the oldest techniques for the treatment of various cancers, particularly for prostate cancer.
The film will focus on current biotechnology “innovation-stagnation” , the current cost of drug development and its stages, and conflicts of interest based on human defense concepts.
This is one of the largest sources of frustration currently among health care companies and investors.
The OneMedResearch January/February 2012 Issue discusses the developments of several small companies with intriguing technology in an emerging market. The report contains full financial updates of those companies designated as research clients as well as profiles of companies OneMedPlace has kept an eye on. This issue is particularly interesting as it comes in the wake of the OneMedForum conference in San Francisco, which brought these and dozens of other featured companies together with hundreds of high net worth investors, consultants, financiers and key opinion leaders. Over 90 companies presented at the conference, a unique educational and networking environment which included panel…